Swiss Chinese Life Sciences Forum 2018, Novartis Campus, Donnerstag, 13. September 2018

The Swiss Chinese Life Sciences Forum 2018 
“Chinese Pharma Goes Global” 

September 13, 2018 / 13:30 – 17:30 plus Networking Apéro
Novartis Campus, Basel
The Chinese Pharma industry is rapidly upgrading its capabilities, moving from being a supplier of basic molecules and generics to becoming a major force in the development of innovative, molecular-targeted treatments and gene-based therapies. The Swiss Chinese Life Sciences Forum 2018 organised by , the Fachhochschule Nordwestschweiz and the Swiss Chinese Chamber of Commerce and hosted by Novartis offers insights into key players in the Chinese Pharma landscape and identifies opportunities for greater collaboration between Swiss and Chinese Pharma.
 Key themes:

Innovation in the Chinese Pharma Industry
Internationalisation – Chinese Pharma companies go global
China’s recent regulatory reform and the impact on innovation 
Swiss Pharma in China – the case of Novartis
Collaboration between European and Chinese Life Sciences companies 

Expert Speakers include:

John Oyler, CEO and Founder of BeiGene 
Nigel Sheail - Head, Mergers & Acquisitions and Business Development & Licensing Novartis International AG, Basel
Bruno Delie - General Manager, Luye Supply AG 
Michael Frizberg - President CMAB Biopharma International 
Larry Zhang - VP, Head of Public Affairs & CSR, Novartis China – Novartis Campus Shanghai Live Transmission
plus Asymchem 

For details visit 

Swiss Chinese Life Sciences Forum 2018

Weitere interessante Veranstaltungen
Holen Event Empfehlungen basierend auf Ihre Facebook-Geschmack. Hol es dir jetzt!Zeigen Sie mir die passenden Veranstaltungen für michNicht jetzt